Correlation Between Visa and Eastgate Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Eastgate Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Eastgate Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Eastgate Biotech Corp, you can compare the effects of market volatilities on Visa and Eastgate Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Eastgate Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Eastgate Biotech.

Diversification Opportunities for Visa and Eastgate Biotech

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Visa and Eastgate is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Eastgate Biotech Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eastgate Biotech Corp and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Eastgate Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eastgate Biotech Corp has no effect on the direction of Visa i.e., Visa and Eastgate Biotech go up and down completely randomly.

Pair Corralation between Visa and Eastgate Biotech

Taking into account the 90-day investment horizon Visa is expected to generate 323.31 times less return on investment than Eastgate Biotech. But when comparing it to its historical volatility, Visa Class A is 166.57 times less risky than Eastgate Biotech. It trades about 0.08 of its potential returns per unit of risk. Eastgate Biotech Corp is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  1.00  in Eastgate Biotech Corp on September 12, 2024 and sell it today you would lose (0.55) from holding Eastgate Biotech Corp or give up 55.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy65.32%
ValuesDaily Returns

Visa Class A  vs.  Eastgate Biotech Corp

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Eastgate Biotech Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eastgate Biotech Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, Eastgate Biotech is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Visa and Eastgate Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Eastgate Biotech

The main advantage of trading using opposite Visa and Eastgate Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Eastgate Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eastgate Biotech will offset losses from the drop in Eastgate Biotech's long position.
The idea behind Visa Class A and Eastgate Biotech Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity